𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The gingival platinum line. A new finding following CIS-dichlorodiammine platinum (II) treatment

✍ Scribed by Lawrence J. Ettinger; Arnold I. Freeman


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
303 KB
Volume
44
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A comparative study of the distribution
✍ R. Harrison; C. A. McAuliffe; A. Zaki; J. Baer; H. Sharma; A. Smith; H. Jackson; πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 571 KB

## Three platinum derivatives, cis-dichlorodiammine platinum (II), (D D P), cis-trans-dichlorodihydroxy-bis-(isopropylamine)platinum (IV) (CHIP) and cis-dichloro-bis-cyclopropylamine platinum (II) (CP), have been prepared with a gamma-emitting platinum label. The distribution of these complexes was

5-fluorouracil and cis-platinum in the t
✍ Land, Vita J. ;Dyment, Paul G. ;Starling, Kenneth ;Strandjord, Sarah E. ;Chan, R πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 189 KB

## Abstract Eleven patients with osteogenic sarcoma (9), Hodgkin disease (1), and mesenchymal sarcoma (1), were treated with 5‐fluorouracil (5‐FU) and cisplatin (DDP). Myelosuppression and vomiting of variable degrees occurred in all. No responses were seen.

Phase II clinical trial of SKI-2053R, a
✍ Noe K. Kim; Seock-Ah Im; Dong-Wan Kim; Moon H. Lee; Chul W. Jung; Eun K. Cho; Jo πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views

BACKGROUND. SKI-2053R (SK Chemicals, Kyungki-Do, South Korea) is a new platinum derivative with antitumor activity against various cell lines, including cisplatin-resistant tumor cell lines. Preclinical studies have suggested that it is less nephrotoxic than cisplatin. This study evaluated the effic